SUMMARY OF LOAN AGREEMENT



OF 


YAMBEAR BIO-TECH, INC.


AS OF JANUARY 15, 2013


 


 


This
term sheet (this “Term Sheet”) summarizes the principal terms of the proposed loan by LIN, Hsin-Lung to
YAMBEAR BIO-TECH, INC., a company incorporated in USA (together with its affiliates and subsidiaries, the “Company”)
by means of note (as defined below) (the “Financing Transaction”).


 


LIN, Hsin-Lung and
the Company intend that the provisions of Part A and B of this Term Sheet to be binding on and enforceable against them (the “Binding
Terms”).


 


Each of LIN, Hsin-Lung,
the Company and the Controlling Shareholders shall be referred to individually herein as a “Party” and collectively
as the “Parties.”


 


***


 


PART A: PRINCIPAL TERMS OF THE LOAN AGREEMENT


 


Key Terms of the Loan Agreement


 


	
        Borrower:

         
	
        YAMBEAR BIO-TECH, INC.

         

	
        Loan Amount:

         
	
        US$150,000 (the “Loan
        Amount”).

         

	
        Use of Proceeds:

         
	
        The proceeds of the Financing
        Transaction shall only be used for remittance in Hong Kong

         

	
        Closing:

         
	
        The closing of the Financing
        Transaction shall occur upon the wire of proceeds (the “Closing”).

         



 


Terms
of Loan


 


	Interest rate:	Interest Rate: Annual interest rate of 0%.
	 	 
	
        Repayment Term:
	
        The day that
is one year. All principal and accrued interest is due and payable on the Maturity Date. [The maturity date can be extended by
one year upon the written notice of LIN, Hsin-Lung.]



 






    	1



    	 



    

 


PART B: MISCELLANEOUS


 


	
        Confidentiality:

         
	
        Neither of the Company
        or the lender will disclose the existence or contents of this Term Sheet to any person(s) other than their respective employees,
        legal counsel, accountants, prospective co-investors and other professional advisors on a need-to-know basis.

         

	
        Governing Law/Dispute
        Resolution:

         
	
        This Term Sheet shall
        be governed by the laws of [Hong Kong], without regard to the conflicts of law principles thereof.

         

        Any dispute, controversy,
        claim or difference of any kind whatsoever arising out of or in connection with this Term Sheet shall be resolved exclusively through
        arbitration administered by the Hong Kong International Arbitration Centre (“HKIAC”) in Hong Kong which shall
        be conducted in accordance with the then effective ICC Rules. The arbitration tribunal shall consist of three arbitrators, who
        shall be appointed as follows: one (1) arbitrator shall be appointed by the claimant(s) to the dispute, one (1) arbitrator shall
        be appointed by the respondent(s) to the dispute, and one (1) arbitrator shall be appointed by the Chairman of HKIAC. The language
        of the arbitration proceedings and written decisions or correspondence shall be English.

         

	
        Counterparts:

         
	
        This Term Sheet may be
        executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one
        and the same instrument. Executed counterparts of this Term Sheet may be exchanged by facsimile or e-mail.

         



 


[remainder of page
intentionally left blank; signature page to follow]




 




    	2



    	 



    

 


	COMPANY 	 
	 	 
	YAMBEAR BIO-TECH, INC. 	 
	 	 
	/s/ Lin, Hsin-Lung



	 
	By: LIN, Hsin-Lung 	 
	Title: CEO 	 
	 	 
	LENDER 	 
	 	 
	LIN, Hsin-Lung Ltd. 	 
	 	 
	/s/ Lin, Hsin-Lung Ltd.	 


 


[signature page to the Term Sheet]


 








    	3